American Capital Advisory’s Exact Sciences EXAS Stock Holding History

American Capital Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$305	–	1159
2025 Q4	$305	Hold	3	–	–	﹤0.01%	863
2025 Q3	$165	Buy	3 +2	+200%	+$100	﹤0.01%	904
2025 Q2	$54	Buy	+1	New	+$51	﹤0.01%	856

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

American Capital Advisory's EXAS Position: Q1 2026 in Review

American Capital Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3 shares — an estimated $305 sold.

American Capital Advisory first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $305 in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

American Capital Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
American Capital Advisory sold 3 Exact Sciences shares in Q1 2026, an estimated $305.
American Capital Advisory first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
American Capital Advisory's Exact Sciences position peaked at $305 in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.